Satiatrim

Willpower in a glass

     "Our studies indicate that Satiatrim is one of the most potent products we have tested in its ability to slow the movement of food from the stomach. Satiatrim offers great promise as an aid to help individuals trying to lose weight".

                                                                                    -Dr David Thompson

                                                                                    Professor of Gastroenterology

                                                                                    Hope Hospital in Manchester England

Although not available as a diet pill, Satiatrim is a delicious drink available in chocolate, vanilla, mixed berry - or in a variety pack, which includes all three flavors. Diet research with a proven track record. Lose weight with Satiatrim today!

Representative results from over 15 trials show Satiatrim:

• Extends the feeling of fullness more than 3½ hours
• Reduces eating by 14% in a meal consumed four hours later
• Stimulates the feel-full protein and slows down the movement of food from the stomach
• Reduces caloric intake by more than 20%

1. OBJECTIVE: Measure the effect of the on the Satiatrim Formulation on satiety in human subjects

No. Subjects: 10
Age: 20-57
BMI: 19-25c
Format: Double blind, placebo controlled

Design: Subjects participated in two satiety tests. They were given the Satiatrim Formulation or a placebo and then consumed a 340-calorie meal. Following consumption of the meal they recorded their ratings of hunger and how much food they could consume on a visual analog scale every 15 minutes for 3½ hours.

Results: Subjects receiving the Satiatrim Formulation experienced a 30% decrease in hunger versus those who received the placebo and showed a 44% decrease in prospective food consumption. The differences were significant at p < .05.

Conclusions: This study demonstrated that the Satiatrim Formulation was more effective than the placebo in reducing hunger 3½ hours after consumption of a meal.

2. OBJECTIVE: Measure the effect of the Satiatrim Formulation on caloric intake of a second meal consumed 3½ hours after an initial one.

No. Subjects: 20
Age: 32-55
BMI: 25-30
Format: Double blind, placebo controlled

Design: Subjects participated in two satiety tests. They were given the Satiatrim Formulation or a placebo and then consumed a 340-calorie meal. Following consumption of the meal they recorded their ratings of hunger and satiety every 15 minutes using a visual analog scale. Three and a half hours later subjects consumed an open-ended meal consisting of macaroni and cheese. The amount of food consumed was weighed and recorded.

Results: Compared to a placebo beverage, the Satiatrim Formulation decreased hunger from 75 minutes through 210 minutes. At 210 minutes hunger was 45.9% less in the Satiatrim Formulation trial. Similar results were seen for satiety. After 3½ hours, subjects receiving the Satiatrim Formulation consumed 154 calories versus 297 calories for the placebo trial. All results were significant at p < .05.

Conclusions: This study demonstrated that the Satiatrim Formulation significantly extended the feeling of fullness and decreased feelings of hunger over 3½ hours. The Satiatrim Formulation also reduced caloric intake by 14% in a second meal consuming 3½ hours later.

3. OBJECTIVE: To measure the effect of the Satiatrim Formulation on gastric emptying following consumption of a standard meal.

No. Subjects: 12
Age: 18-65
BMI: 25-29.9
Format: Double blind, placebo controlled

Design: On each study day subjects consumed either the Satiatrim Formulation or a placebo. They then consumed a radiolabeled test meal consisting of a two-egg omelet, white bread, butter and water. Scintigraphic images were taken at five-minute intervals for three hours after consumption of the test meal, and at 10-minute intervals for the next three hours.

Results: The Satiatrim Formulation significantly reduced the rate of gastric emptying following consumption of a test meal compared to placebo. There was a 30% decrease in the rate of gastric emptying of the solid phase of the meal and a 40% decrease in the rate of gastric emptying of the liquid phase. p < .03

Conclusions: This study demonstrated that the Satiatrim Formulation significantly decreases the rate of a meal's gastric emptying when compared to a placebo, and that the probable mode of action of the Satiatrim Formulation is through the activation of cholecystokinin release.

4. OBJECTIVE: To measure the effect of the Satiatrim Formulation on caloric intake.

No. Subjects: 20
Age: 21-45
BMI: 25-31
Format: Double blind, placebo controlled, crossover

Design: Subjects were given the Satiatrim Formulation or a placebo. They were then provided with a pasta lunch and instructed to consume as much food as they wished within 25 minutes. The amount of food consumed was measured and recorded. Following lunch, subjects were asked to complete visual analog scale assessments for hunger, fullness and how much food they wanted to eat. VAS assessments were recorded immediately after lunch and 30, 60, 90, 120, 150 and 180 minutes after lunch.

Results: Subjects receiving the Satiatrim Formulation showed a 20.9% reduction in caloric intake compared to subjects receiving the placebo (p < 0.5). There was also an extension of satiety at three hours as measured by the VAS ratings.

Conclusions: This study demonstrated that the Satiatrim Formulation decreased caloric intake. Additionally, subjects consuming the Satiatrim Formulation demonstrated an increase in feelings of satiety when compared to the placebo despite consuming significantly fewer calories.